Fig. 1From: What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO)Prognostic value of tumor-infiltrating lymphocytes on residual disease after neo-adjuvant chemotherapy for triple-negative breast cancer. [22] Estimated Kaplan–Meyer curves of metastasis-free survival a and overall survival b for all patientsBack to article page